Cargando…

Markers of Angiogenesis in Ovarian Cancer

Tumor development and progression are inherently dependent on the process of angiogenesis. Recently, anti-angiogenic therapy has started to show promise as an effective treatment strategy in many solid tumors including ovarian carcinoma. Unfortunately, lack of effective biomarkers presents a challen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merritt, William M., Sood, Anil K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850853/ https://www.ncbi.nlm.nih.gov/pubmed/18057525 http://dx.doi.org/10.1155/2007/257602

Ejemplares similares

Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review
por: Terry, Kathryn L., et al.
Publicado: (2004)

Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer
por: Brinkhuis, Mariël, et al.
Publicado: (2002)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

Early Detection of Ovarian Cancer
por: Badgwell, Donna, et al.
Publicado: (2007)

Claudin Proteins in Ovarian Cancer
por: Morin, Patrice J.
Publicado: (2007)

Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
por: Horala, Agnieszka, et al.
Publicado: (2017)

Transforming Growth Factor-β and Nitrates in Epithelial Ovarian Cancer
por: Khalifa, Ali, et al.
Publicado: (1999)

Non-Genomic Biomarkers of Risk in Ovarian Cancer
por: Pinheiro, Simone P., et al.
Publicado: (2007)

Prognostic and Predictive Markers in Cancer
por: Conley, Barbara A., et al.
Publicado: (2004)

Platelet-Stored Angiogenesis Factors: Clinical Monitoring Is Prone to Artifacts
por: Starlinger, Patrick, et al.
Publicado: (2011)

Genetic Counselling and Testing for Hereditary Breast and Ovarian Cancer: The Gent(le) Approach
por: De Vos, M., et al.
Publicado: (1999)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Epigenetic Markers and Response to Chemotherapy in Cancer
por: Strathdee, Gordon
Publicado: (2007)

Alternative Spliced Transcripts as Cancer Markers
por: Caballero, Otavia L., et al.
Publicado: (2001)

Development Tracks for Cancer Prevention Markers
por: Baker, Stuart G., et al.
Publicado: (2004)

Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007)

Use of Markers for the Detection and Treatment of Lung Cancer
por: Vourlekis, Jason S., et al.
Publicado: (2004)

NOTCH signalling in ovarian cancer angiogenesis
por: Perez-Fidalgo, Jose Alejandro, et al.
Publicado: (2020)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe
por: Morrison, P. J., et al.
Publicado: (1999)

Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer
por: Page, Robert E., et al.
Publicado: (2007)

Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research
por: Gimotty, Phyllis A., et al.
Publicado: (2007)

Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry
por: Bergen, H. Robert, et al.
Publicado: (2004)

A Proteomic Approach to the Identification of Lung Cancer Markers
por: Hanash, Samir, et al.
Publicado: (2001)

Characterization of Plasma Membrane Proteins from Ovarian Cancer Cells Using Mass Spectrometry
por: Springer, David L., et al.
Publicado: (2004)

Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
por: Troyer, D. A., et al.
Publicado: (2004)

Investigating Population Risk Factors of Pancreatic Cancer by Evaluation of Optical Markers in the Duodenal Mucosa
por: Turzhitsky, Vladimir, et al.
Publicado: (2008)

Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
por: Pretorius, Maria E., et al.
Publicado: (2009)

Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
por: Gavalas, Nikos G., et al.
Publicado: (2013)

A network model for angiogenesis in ovarian cancer
por: Glass, Kimberly, et al.
Publicado: (2015)

Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
por: Cui, Hengmi
Publicado: (2007)

Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
por: Javidroozi, Mazyar, et al.
Publicado: (2012)

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression
por: Srivastava, Meera, et al.
Publicado: (2001)

Isolation and Identification of Concanavalin A Binding Glycoproteins from Human Seminal Plasma: A Step Towards Identification of Male Infertility Marker Proteins
por: Tomar, Anil Kumar, et al.
Publicado: (2011)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2010)

Dickkopf-3 As a New Potential Marker for Neoangiogenesis in Colorectal Cancer: Expression in Cancer Tissue and Adjacent Non-Cancerous Tissue
por: Zitt, Matthias, et al.
Publicado: (2008)

Helicobacter pylori: Determinant and Markers of Virulence
por: Mascellino, M. T., et al.
Publicado: (2009)

Fucosylated Glycoproteins as Markers of Liver Disease
por: Mehta, Anand, et al.
Publicado: (2008)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1hid72fu3ea2c6jb0ol9kqgk1s